These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 23595832
1. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, Quinn K, King L, Schmink SE, Wang X, Mayer LW, Clark TA, Gaskell JR, Messonnier NE, DiOrio M, Cohn AC. Clin Infect Dis; 2013 Aug; 57(3):344-8. PubMed ID: 23595832 [Abstract] [Full Text] [Related]
2. Risk factors for meningococcal disease in students in grades 9-12. Harrison LH, Kreiner CJ, Shutt KA, Messonnier NE, O'Leary M, Stefonek KR, Lin H, Lynfield R, Barrett NL, Arnold KE, Jones TF, Montero JT, Meningococcal High School Study Group. Pediatr Infect Dis J; 2008 Mar; 27(3):193-9. PubMed ID: 18277925 [Abstract] [Full Text] [Related]
4. Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. Mutonga DM, Pimentel G, Muindi J, Nzioka C, Mutiso J, Klena JD, Morcos M, Ogaro T, Materu S, Tetteh C, Messonnier NE, Breiman RF, Feikin DR. Am J Trop Med Hyg; 2009 Apr; 80(4):619-24. PubMed ID: 19346388 [Abstract] [Full Text] [Related]
5. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Weiss D, Stern EJ, Zimmerman C, Bregman B, Yeung A, Das D, Dentinger CM, Marx MA, Kornblum J, Lee L, Halse TA, Mayer LW, Hatcher CP, Theodore MJ, Schmink S, Harcourt BH, Zucker JR, Layton M, Clark TA, New York City Meningococcal Investigation Team. Clin Infect Dis; 2009 Apr 01; 48(7):894-901. PubMed ID: 19231975 [Abstract] [Full Text] [Related]
6. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Brooks R, Woods CW, Benjamin DK, Rosenstein NE. Clin Infect Dis; 2006 Jul 01; 43(1):49-54. PubMed ID: 16758417 [Abstract] [Full Text] [Related]
10. First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak. McNamara LA, Shumate AM, Johnsen P, MacNeil JR, Patel M, Bhavsar T, Cohn AC, Dinitz-Sklar J, Duffy J, Finnie J, Garon D, Hary R, Hu F, Kamiya H, Kim HJ, Kolligian J, Neglia J, Oakley J, Wagner J, Wagner K, Wang X, Yu Y, Montana B, Tan C, Izzo R, Clark TA. Pediatrics; 2015 May 01; 135(5):798-804. PubMed ID: 25917990 [Abstract] [Full Text] [Related]
12. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. Gagneux SP, Hodgson A, Smith TA, Wirth T, Ehrhard I, Morelli G, Genton B, Binka FN, Achtman M, Pluschke G. J Infect Dis; 2002 Mar 01; 185(5):618-26. PubMed ID: 11865418 [Abstract] [Full Text] [Related]
15. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine. Rose WE. J Am Pharm Assoc (2003); 2014 Mar 01; 54(2):198-201. PubMed ID: 24632933 [No Abstract] [Full Text] [Related]
18. Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease. La EM, Talbird SE, Kanadanian KV, Huang L, Fain J, Srivastava A. Hum Vaccin Immunother; 2019 Mar 01; 15(4):978-986. PubMed ID: 30526279 [Abstract] [Full Text] [Related]
20. [Outbreak of serogroup C meningococcal disease among teenagers in Randers--preventive measures and examination of the meningococcal carrier conditions]. Rønne T, Buhl LH, Lind I. Ugeskr Laeger; 1995 Aug 07; 157(32):4454-8. PubMed ID: 7483025 [Abstract] [Full Text] [Related] Page: [Next] [New Search]